ESPEROCT
STN: BL 125671
Proper Name: Antihemophilic Factor (Recombinant), GlycoPEGylated-exei
Tradename: ESPEROCT
Manufacturer: Novo Nordisk, Inc.
Indication:
- For use in adults and children with hemophilia A for: (1) on-demand treatment and control of bleeding episodes, (2) perioperative management of bleeding, and (3) routine prophylaxis to reduce the frequency of bleeding episodes.